Cargando…

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics

Atherosclerotic diseases may include femoropopliteal artery stenosis or occlusion. Percutaneous transluminal angioplasty (PTA) is an effective and minimally invasive treatment strategy for atherosclerotic femoropopliteal artery stenosis/occlusion disease. Balloon angioplasty is a widely used techniq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xin, Wang, Feng, Wu, Dan-ming, Zhang, Min-hong, Jia, Xin, Zhang, Ji-wei, Zhuang, Bai-xi, Zhao, Yu, Guo, Ping-fan, Bi, Wei, Fu, Wei-guo, Guo, Wei, Wang, Shen-ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455750/ https://www.ncbi.nlm.nih.gov/pubmed/30921183 http://dx.doi.org/10.1097/MD.0000000000014840

Ejemplares similares

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease
por: Ren, Hao, et al.
Publicado: (2021)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
por: Haraguchi, Takuya, et al.
Publicado: (2023)

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions
por: Ni, Leng, et al.
Publicado: (2022)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
por: Schroeder, Henrik, et al.
Publicado: (2017)

Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis
por: Feng, Hai, et al.
Publicado: (2020)

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
por: Shirai, Shigemitsu, et al.
Publicado: (2022)

Efficacy of Super Slow Inflation as Lesion Preparation for Drug-Coated Balloons in Femoropopliteal Lesions
por: Sugihara, Makoto, et al.
Publicado: (2020)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Improving the Outcomes of Complex Lesions of the Femoropopliteal Artery Using Atherectomy and Drug Coated Balloon
por: Kim, Sangmin
Publicado: (2022)

One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
por: Yu, Xiaoxi, et al.
Publicado: (2021)

Paclitaxel-coated balloons angioplasties for extra-long femoropopliteal artery atherosclerotic lesions (> 30 cm):12 months outcomes from a single center
por: Pan, Tao, et al.
Publicado: (2022)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease
por: Cha, Jung-Joon, et al.
Publicado: (2021)

Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2016)

Association between post-balloon angioplasty dissection and primary patency in complex femoropopliteal artery disease: 2-year clinical outcomes of the AcoArt I trial
por: Ren, Hao, et al.
Publicado: (2021)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020)

Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

Feasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal Disease
por: Jang, Shih-Jung, et al.
Publicado: (2015)

Multiple drug-coated balloons can be used effectively for peripheral arterial disease including long femoropopliteal lesions
por: Chu, Wongong, et al.
Publicado: (2021)

Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment
por: Zhang, Bihui, et al.
Publicado: (2021)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease
por: Stavroulakis, Konstantinos, et al.
Publicado: (2022)

The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2016)

One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial
por: Lai, Zhichao, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions
por: Weinstock, Barry, et al.
Publicado: (2014)

BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year Outcomes with Propensity Matching for Drug-Coated Balloons
por: Piorkowski, Michael, et al.
Publicado: (2023)

Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup
por: Kobayashi, Norihiro, et al.
Publicado: (2019)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study
por: Shammas, Nicolas W, et al.
Publicado: (2022)

Erratum to: The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial
por: Teichgräber, U., et al.
Publicado: (2017)

Paclitaxel-coated balloon dilation for central airway obstruction
por: Sakata, Kenneth K., et al.
Publicado: (2018)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Katsanos, Konstantinos, et al.
Publicado: (2018)

Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials
por: Klumb, Christof, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_04en41cqk3f65nclssnqfg786m